SNTI is trading 5.4% down at $1.03 in after-hours trading with no clear catalyst for the move.
- The stock has slipped below its June 26 close of $1.09 following a volatile week that included a sharp 16.8% gain on June 24.
- No fresh company-specific news, earnings, or major analyst calls have been reported to explain the decline.
- The move currently appears to be typical low-liquidity biotech volatility rather than a reaction to a disclosed event.